{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:34:17Z","timestamp":1767926057831,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2990,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.bbmt.2006.10.005","type":"journal-article","created":{"date-parts":[[2007,1,21]],"date-time":"2007-01-21T07:08:28Z","timestamp":1169363308000},"page":"235-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies"],"prefix":"10.1016","volume":"13","author":[{"given":"Trudy N.","family":"Small","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Castro-Malaspina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.10.005_bib1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198712243172602","article-title":"Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia","volume":"317","author":"Brochstein","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V91.3.1083","article-title":"T-cell\u2013depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease","volume":"91","author":"Papadopoulos","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1200\/JCO.1994.12.6.1217","article-title":"Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total body irradiation","volume":"12","author":"Michel","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1999.17.5.1545","article-title":"Improved outcome with T-cell\u2013depleted bone marrow transplantation for acute leukemia","volume":"17","author":"Aversa","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbmt.2004.09.010","article-title":"Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia","volume":"11","author":"Oehler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V99.6.1971","article-title":"Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation","volume":"99","author":"Weisdorf","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/bbmt.2002.v8.abbmt080601","article-title":"Comparable outcome with T-cell\u2013depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation","volume":"8","author":"Alyea","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood.V86.8.3247.3247","article-title":"Unrelated donor marrow transplantation in children","volume":"86","author":"Balduzzi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.1997.3593173.x","article-title":"Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission","volume":"99","author":"Chown","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(97)03098-5","article-title":"Outcome of transplantation with matched sibling and unrelated donor bone marrow in children with leukaemia","volume":"350","author":"Hongeng","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/blood.V69.4.1015.1015","article-title":"Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies","volume":"69","author":"Blume","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","article-title":"A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study","volume":"81","author":"Blume","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V89.11.4226","article-title":"Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose","volume":"89","author":"Sierra","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1702519","article-title":"Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience","volume":"26","author":"Sierra","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bmt.1702690","article-title":"Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia","volume":"26","author":"Michallet","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bmt.1704689","article-title":"Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia","volume":"34","author":"Nemecek","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/bbmt.2002.v8.pm11939604","article-title":"Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study","volume":"8","author":"Andersson","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","article-title":"Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome","volume":"100","author":"Deeg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib19","first-page":"324","article-title":"Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies","volume":"3","author":"Long","year":"1997","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.1121","article-title":"Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia","volume":"67","author":"Bibawi","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1704867","article-title":"High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia","volume":"35","author":"Farag","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib22","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V94.4.1237","article-title":"Phase I study of (131)I\u2013anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome","volume":"94","author":"Matthews","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib23","first-page":"495","article-title":"A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies","volume":"18","author":"Vey","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bmt.1701276","article-title":"Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen","volume":"22","author":"Matsuyama","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib25","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1991.9.10.1880","article-title":"Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy","volume":"9","author":"Phillips","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib27","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib28","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib29","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in acute leukemia","volume":"18","author":"Mrozek","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2006.10.005_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.10.005_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/sim.4780120803","article-title":"Kaplan-Meier, marginal, or conditional probability curves in summarizing competing risks failure time data","volume":"12","author":"Pepe","year":"1993","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2006.10.005_bib35","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2004-07-2929","article-title":"Transfusion-related acute lung injury","volume":"105","author":"Silliman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","article-title":"Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia","volume":"9","author":"Doney","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib37","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198712243172602","article-title":"Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia","volume":"317","author":"Brochstein","year":"1987","journal-title":"N Eng J Med"},{"key":"10.1016\/j.bbmt.2006.10.005_bib38","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib40","first-page":"397","article-title":"Addition of low-dose folinic acid to a methotrexate\/cyclosporin A regimen for prevention of acute graft-versus-host disease","volume":"14","author":"Russell","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib41","first-page":"349","article-title":"Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation","volume":"9","author":"Nevill","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbmt.2004.10.008","article-title":"Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation","volume":"11","author":"Wong","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.005_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.moh.0000148762.05110.56","article-title":"Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease","volume":"12","author":"Burroughs","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib44","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.10.005_bib45","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","article-title":"Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age","volume":"105","author":"Alyea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.leu.2404010","article-title":"Myeloablative versus nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis","volume":"20","author":"Scott","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.10.005_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.seminhematol.2005.09.005","article-title":"Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion","volume":"43","author":"Porter","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib48","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.005_bib49","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1158\/1078-0432.CCR-04-1040","article-title":"In vitro stimulation with WT1 peptide\u2013loaded Epstein-Barr virus\u2013positive B cells elicits high frequencies of WT1 peptide\u2013specific T cells with in vitro and in vivo tumoricidal activity","volume":"10","author":"Doubrovina","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2006.10.005_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1532\/IJH97.05107","article-title":"WT1(235), a ninemer peptide derived from Wilms\u2019 tumor gene product, is a candidate peptide for the vaccination of HLA-A*0201\u2013positive patients with hematopoietic malignancies","volume":"82","author":"Li","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2006.10.005_bib51","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","article-title":"Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells","volume":"88","author":"Molldrem","year":"1996","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910600677X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910600677X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:25Z","timestamp":1761056845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910600677X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S108387910600677X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.10.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}